|
HS Code |
799479 |
| Product Name | Nocodazole |
| Chemical Formula | C14H11N3O3S |
| Molecular Weight | 301.33 g/mol |
| Cas Number | 31430-18-9 |
| Appearance | yellow crystalline powder |
| Solubility | DMSO, ethanol, methanol |
| Purity | ≥98% |
| Storage Temperature | -20°C |
| Mechanism Of Action | microtubule depolymerizing agent |
| Application | cell cycle synchronization |
| Synonyms | Methyl[5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl]carbamate |
| Melting Point | 216-218°C |
| Target | tubulin |
| Hazard Statements | H302, H315, H319, H335 |
As an accredited Nocodazole factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Nocodazole is supplied in a 25 mg amber glass vial, sealed, labeled with compound name, CAS number, and storage instructions. |
| Shipping | Nocodazole is shipped in tightly sealed containers under cool conditions, often with ice packs or dry ice to maintain stability. The packaging complies with hazardous material regulations, ensuring safe transport. Appropriate documentation and labeling for toxic substances are included, and shipping is typically expedited to prevent degradation of the chemical. |
| Storage | Nocodazole should be stored at -20°C, protected from light and moisture to ensure stability and potency. The chemical should be kept in a tightly sealed container, preferably under an inert gas if available. Upon dissolution, the solution can be stored at -20°C or lower, and repeated freeze-thaw cycles should be avoided to prevent degradation. |
Applications of Nocodazole in Industrial ManufacturingNocodazole plays a key role in several specialized industrial sectors, particularly where modulation of microtubule polymerization is required. As an established agent with precise biological activity, it supports complex processes across biopharmaceutical manufacturing, academic research reagents, high-content screening supplies, and cytogenetic analysis kits. Below, we detail its application in real manufacturing contexts. 1. Biopharmaceutical Cell Cycle SynchronizationBiotech manufacturers routinely employ Nocodazole to synchronize cell cultures at the G2/M phase during the production of recombinant proteins and monoclonal antibodies, ensuring consistent expression profiles and yields. By arresting cell division at a distinct point, process engineers achieve tight control over batch timing and product quality. This is particularly relevant in large-scale perfusion and batch fermenters using mammalian cell lines such as CHO and HEK293, where maintaining homogeneity across cell populations directly impacts downstream purification and assay performance. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Laboratory Research Grade Reagent ProductionManufacturers of research and diagnostic reagents rely on Nocodazole as a control compound for in vitro cytoskeletal assays, mitotic index determination, and functional studies on microtubule dynamics. It forms a core component in assay kits supplied to academic labs and contract research organizations. Batch-to-batch consistency, verified potency, and biological accuracy are essential to meet the requirements of research protocol reproducibility in both cell biology screening and mechanistic drug discovery platforms. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. High-Content Screening (HCS) Platform SupplyProducers of automated high-content screening platforms incorporate Nocodazole into compound libraries to serve as a positive control for mitotic arrest and microtubule disruption, supporting quantitative analysis of antimitotic drug candidates. Integration at this level demands validated, stable formulations aligned with robotics-compatible dispensing, as well as established efficacy in standardized cell lines used for throughput screening of small molecules in drug discovery and cytotoxicity profiling workflows. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Cytogenetic Analysis Kit ManufacturingSpecialized kit manufacturers utilize Nocodazole in cytogenetic analysis to enrich mitotic cells and improve chromosomal spreads, enabling clear karyotype visualization during prenatal testing, oncological diagnostics, and research. Consistent performance and defined concentration ranges are vital to support FISH (fluorescence in situ hybridization), G-banding, and other chromosomal preparation methods used by cytogenetics and pathology laboratories worldwide. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive Nocodazole prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Decades spent in chemical synthesis teach a few things. Over the years, our labs have produced thousands of small molecules, custom reagents, and bioactive compounds, but Nocodazole stands apart. Our chemists understand every nuance of its structure, every variable in its synthesis, and every quirk in its behavior under strong light, varying pH, and storage conditions. Nocodazole was not the first compound we synthesized, nor the last, but its widespread use in cell cycle research and in the biotechnology industry creates persistent demand and encourages us to refine our process at each batch scale.
We manufacture Nocodazole under controlled environments with careful consideration for purity and consistency. The product's model, we offer, follows industry-accepted nomenclature and chemical identifiers such as CAS number 31430-18-9 and molecular formula C14H11N3O3S. Our routine synthesis yields a pale yellow crystalline powder, which dissolves readily in dimethyl sulfoxide (DMSO) and ethanol. Customers often ask why our batches seem to produce more reliable results in spindle inhibition assays. The rigorous in-process QC, the selection of high-purity starting materials, and years of procedural optimization account for that difference. We focus on maintaining batch-to-batch reproducibility, which enables scientists to trust their results rather than question the basics.
Our chemists synthesize Nocodazole using established protocols, monitored at every stage with analytical tools such as HPLC, NMR, and mass spectrometry. The final product always undergoes a full identity and purity confirmation before packaging. Manufacturing at scale means tracking every parameter—reaction time, temperature, reagent ratio—on digital batch logs. Small changes affect yield or impurity profile. We learned this the hard way when a pilot batch years ago displayed low solubility due to inadvertent formation of a byproduct; adjusting reaction pH during the work-up resolved that. Each batch exits our doors with documentation supporting purity ≥ 98% (often higher), low water content, and absence of residual solvents.
For academic groups, clinicians, and biotechs pursuing spindle poisons, reproducibility matters most. We regularly track feedback from researchers using Nocodazole in microtubule assays. Some labs freeze aliquots for months, reporting stability and unchanging performance. Others detail how lower-grade samples from outside sources contributed to unexpected outcomes in cytometry or immunofluorescence work. We take these experiences seriously. Reliability is not marketing fluff; it’s the core of what we do.
Nocodazole acts by disrupting microtubule polymerization. This property places it in the toolkit of anyone studying cell division, cell cycle checkpoint, and structural cell biology. The compound induces G2/M arrest, making it essential for studies mapping molecular pathways in mitosis. Beyond basic research, Nocodazole supports high-content screening, anti-cancer drug discovery, and regenerative medicine approaches. Its effects, reversible upon removal, create predictable blocks in the cell cycle. In our own work with collaborators, synchronized cultures help map kinome activation profiles and dissect mechanisms in anti-proliferative testing.
Few compounds have as lasting a reputation in academia and industry as Nocodazole. Since its introduction, it has become the standard control for microtubule depolymerization. Researchers value its predictable activity and rapid reversibility. Working with teams worldwide, we see the variety in experimental design, yet Nocodazole never strays from spindle checkpoint assays, chromosome alignment tests, or time-lapse imaging of live cells. Our technical support team regularly advises on concentration, diluent selection, and optimal exposure times based on the feedback we gather and literature we follow.
The industry often draws comparisons between Nocodazole and structurally related spindle inhibitors. Colchicine, vinblastine, paclitaxel, and oryzalin also interfere with microtubule dynamics but each compound shows unique properties. With Nocodazole, users report higher specificity in tubulin binding, less off-target cytotoxicity in non-dividing cells, and greater control in achieving G2/M block than with colchicine. Unlike paclitaxel—which stabilizes microtubules and prevents their breakdown—Nocodazole destabilizes and encourages depolymerization. This key difference is not a semantic point but a practical matter that influences every experiment planning step.
Vincristine and vinblastine, plant-derived vinca alkaloids, have clinical usage as chemotherapeutic drugs. Nocodazole rarely enters the clinic (except as an experimental tool) due to its lack of oral bioavailability and pharmacokinetic profile. Instead, it enables researchers to dissect the mechanics of microtubule turnover, checkpoint fidelity, and drug resistance in a controlled dish environment. Calls for high-quality Nocodazole arise from institutions focusing on neurological disorders, since microtubules anchor many neuronal processes. Our product’s low endotoxin level and minimal extraneous particulates have satisfied even the most scrutiny-driven labs working with sensitive primary cells.
Nocodazole’s role keeps expanding as stem cell biology, organoid generation, and single-cell omics push into new territory. Many scientists now use live-cell imaging, automation, and high-throughput systems that demand even more rigorous reagent reproducibility. Every year, our technical team updates protocols in response to new discoveries. For instance, single-cell transcriptomics has revealed how precisely timed Nocodazole treatments can synchronize populations, allowing rare cell fate decisions to be captured for further analysis. Our partnerships with hospitals and pharma companies have also shown that Nocodazole batch performance matters when exploring synergistic drug effects in combinations targeting mitosis.
As regulatory requirements tighten and journal standards climb, labs need to trace every chemical’s provenance. We document each lot, test for heavy metals, and provide full analytical reports on demand. Lab heads appreciate this—not from a regulatory standpoint alone, but because reproducibility lowers wasted time and costs downstream. We remember our own frustrations sourcing inconsistent reagents in early days, so these insights guide our daily routines.
Stability means more than just time on the shelf. Nocodazole survives for years under correct storage—tightly sealed, desiccated, and away from high humidity. Some vendors overlook the need for opaque containers or temperature tracking in supply chains. In our operation, silica packs and temperature indicators come standard, reducing risk during transit. Once in the lab, we suggest researchers use fresh aliquots from the main vial. Our experience shows that repeated freeze-thaw cycles, humidity ingress, or accidental warming can degrade performance. We share everything we know, because months of careful cell preparation should not fail from poor storage steps.
Some researchers contact us with unexpected clumping, lower-than-reported activity, or batch variability. Usually, these issues track back to suboptimal storage, solvent selection, or overexposure to light and moisture. Years ago, we studied solubility at varying pH—and documented how Nocodazole’s dissolution profile shifts in basic or acidic environments. By helping labs avoid common dissolution errors, we save them days of repeated trials.
On rare occasions, we’ve shipped Nocodazole worldwide under severe temperature stress—customs delays, extended transport, high ambient heat. We have since upgraded all logistics partners, implemented more robust packaging, and offered expedited shipment for heat-sensitive orders. We know what it feels like to see a promising set of experiments derailed by an unexpected chemical failure—so every step in our process runs with the end user’s success in mind.
We stay engaged with the community beyond the transaction. Our chemists, QC specialists, and support team routinely field technical queries about Nocodazole—whether confirming compatibility with new microscopy stains or optimizing treatment timing. Our own laboratory pilot studies have fed into published methods—giving direct, first-hand knowledge that guides our customer protocols. Several collaborative projects with academic groups have led us to develop improved packaging, test for overlooked contaminants, and share troubleshooting tips.
More than simply moving chemical units, our team sees itself as partners in each research journey. We’ve seen PhD projects, grant deadlines, and urgent patient-derived cell work all hinge on the uncompromising quality of input reagents. Years of reading user publications built up an internal database of experience: which methodologies succeed, which stumble on details. This feedback cycle drives product and service improvements.
In direct conversations with biologists and product managers, some themes recur. How do we ensure purity in every batch? Every kilogram runs through verification by NMR, HPLC, and MS, checked against archived spectra. What solvents work best? DMSO remains the gold standard, though ethanol and methanol solutions also perform well if sterility and stability requirements are addressed. Is the product suitable for sensitive primary cells? Based on our endotoxin and heavy metals testing, yes—many groups trust it for delicate work.
Can Nocodazole’s reversible action change experimental outcomes? Absolutely. Its profile gives unique temporal control; removing the compound allows microtubules to reform, letting time-course studies unfold precisely. Do we track the experience of published groups? Years spent reading, troubleshooting, and responding to researchers worldwide shapes our product development and day-to-day advice. Transparency, depth of knowledge, and careful record-keeping are habits formed by both success and failure.
The experience of synthesizing and supplying Nocodazole at scale reveals much about the broader industry. As demand for cell synchronization and spindle poisons rose, so did scrutiny over purity, traceability, and documentation. Brokers and third-party sellers have sometimes cut corners, repackaged aged material, or failed to provide full support. Labs switching sources report headaches ranging from insoluble material to surprising impurity peaks. These stories drive us to continually invest in analytical capacity, training, and logistics. Direct engagement means we stand behind every vial, learned from every complaint, and shared our evolving improvements.
A surprising lesson: clear, timely technical support proves as vital as chemical quality alone. We make it easy for scientists to reach us, extend advice from published protocols and unpublished test runs alike, and stay curious about each new application. One researcher’s puzzle can unlock insights for many, and our position at the manufacturing bench gives us a unique vantage point.
We believe Nocodazole deserves its place as a staple reagent in cell biology labs worldwide. Years immersed in its synthesis and use have honed not only our processes, but our appreciation for science’s daily realities—deadlines, batch-to-batch worries, and the complex choreography of logistical and technical challenges. Each improvement, whether it’s a tweak to crystallization or a new transport safeguard, solves problems rooted in real experience.
As research moves forward, each project brings fresh perspective. Our ongoing dialogue with scientists using Nocodazole in everything from drug screens to regenerative studies shapes our innovations and future-proofing. We take pride in every batch, well aware that its performance underpins not just experiments, but careers, discoveries, and maybe the next step in understanding life at the smallest scales. Real experience—a mix of method, skill, and listening to the scientific community—remains our sharpest tool.